Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data

OBJECTIVE: To compare drug survival of biological therapies in patients with rheumatoid arthritis (RA), and analyze the determinants of discontinuation probabilities and switches to other biological therapies. MATERIALS AND METHODS: Consecutive RA patients initiating first biological treatment in on...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clinicoecon Outcomes Res
Egile Nagusiak: Brodszky, Valentin, Bíró, Anikó, Szekanecz, Zoltán, Soós, Boglárka, Baji, Petra, Rencz, Fanni, Tóthfalusi, László, Gulácsi, László, Péntek, Márta
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2017
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5317255/
https://ncbi.nlm.nih.gov/pubmed/28243133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S124381
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak